MiMedx appoints Todd Newton interim CEO; 2022 revenue growth outlook at low end of prior range

MIMEDX GROUP, INC.

Timothy R. Wright terminated as CEO effective immediately; K. Todd Newton appointed interim CEO.
Board formed Search Committee to find permanent CEO; includes Behrens, Bierman, Hawkins.
Board reduced to eight members; Newton no longer independent; Laurencin appointed to Audit Committee.
2022 full-year AWC product net sales expected at low end of 11-14% growth range (2021: $240M).
Q3 2022 AWC product net sales expected mid-single-digit growth vs Q3 2021 ($62.3M); total net sales expected to grow.

item 5.02 item 7.01 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Timothy R. Wright

Chief Executive Officer

MDXG · MIMEDX GROUP, INC.

Effective: 2022-09-03
Successor: K. Todd Newton
Filed: September 6, 2022, 7:59 PM ET

Mr. Wright also ceased to be a member of the board of directors effective upon the termination of his employment as Chief Executive Officer.

Appointed (interim)

K. Todd Newton

Interim Chief Executive Officer

MDXG · MIMEDX GROUP, INC.

Effective: 2022-09-03
Filed: September 6, 2022, 7:59 PM ET

appointed K. Todd Newton, a current director of the Company, as the Company’s interim Chief Executive Officer to replace Timothy R. Wright effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy R. Wright was terminated as Chief Executive Officer at MIMEDX GROUP, INC..

Action: terminated
Role: Chief Executive Officer

Exact text from the filing

Mr. Wright also ceased to be a member of the board of directors effective upon the termination of his employment as Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

K. Todd Newton was appointed as Interim Chief Executive Officer at MIMEDX GROUP, INC..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

appointed K. Todd Newton, a current director of the Company, as the Company’s interim Chief Executive Officer to replace Timothy R. Wright effective immediately.

View on SEC.gov

MIMEDX GROUP, INC. filing history →

Source: SEC EDGAR

accession 0001376339-22-000112

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.